Santiago Aguadé-Bruix

Santiago Aguadé-Bruix

Auto-generated profile, based on publicly available information

Santiago Aguadé-Bruix

Universitat Autónoma de Barcelona

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2011 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
CHCristina Hernández
Cristina Hernández
JCJaume Candell-Riera
Jaume Candell-Riera
Andreea Ciudin MihaiAndreea Ciudin Mihai
Andreea Ciudin Mihai
GFGemma Francisco
Gemma Francisco
SASantiago Aguadé-Bruix
Santiago Aguadé-Bruix
Rafael SimóRafael Simó
Rafael Simó
Background: Given the elevated risk of cardiovascular events and the higher prevalence of silent coronary artery disease (CAD) in diabetic versus non-diabetic patients, the need to screen asymptomatic diabetic patients for CAD assumes increasing importante. The aims of the study were to assess prospectively the prevalence and risk factor predictors of true silent myocardial ischemia (myocardial perfusion defects in the absence of both angina and ST-segment depression) in asymptomatic type 2 diabetic patients. Methods: Stress myocardial perfusion gated SPECT (Single Photon Emission Computed Tomography) was carried out in 41 type 2 diabetic patients without history of cardiovascular disease (CVD) and 41 nondiabetic patients matched by age and gender. Results: There were no significant differences between the two groups regarding either the classic CVD risk factors or left ventricular function. True silent ischemia was detected in 21.9% of diabetic patients but only in 2.4% of controls (p < 0.01). The presence of myocardial perfusion defects was independently associated with male gender and the presence of diabetic retinopathy (DR). The probability of having myocardial perfusion defects in an asymptomatic diabetic patient with DR in comparison with diabetic patients without DR was 11.7 [IC95%: 3.7-37]. Conclusions: True silent myocardial ischemia is a high prevalent condition in asymptomatic type 2 diabetic patients. Male gender and the presence of DR are the risk factors related to its development.

1 January 1997 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
JCJoan Castell Conesa
Joan Castell Conesa
CBCésar Santana Boado
César Santana Boado
SBSantiago Aguadé Bruix
Santiago Aguadé Bruix
TCTeresa Canela
Teresa Canela
ABAmparo García Burillo
Amparo García Burillo
JSJordi Soler Soler
Jordi Soler Soler

1 April 2009 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
JCJaume Candell-Riera
Jaume Candell-Riera
GRGuillermo Romero-Farina
Guillermo Romero-Farina
SASantiago Aguadé-Bruix
Santiago Aguadé-Bruix
JCJoan Castell-Conesa
Joan Castell-Conesa
GLGustavo de León
Gustavo de León
DGDavid García-Dorado
David García-Dorado

Verified
Journal Article
Open access
PDF file
JHJosé Raúl Herance
José Raúl Herance
Rafael SimóRafael Simó
Rafael Simó
MVMayra Alejandra Velasquez
Mayra Alejandra Velasquez
BPBruno Paun
Bruno Paun
DGDaniel García-Leon
Daniel García-Leon
SASantiago Aguadé-Bruix
Santiago Aguadé-Bruix
Background: Systemic insulin resistance is generally postulated as an independent risk factor of cardiovascular events in type 2 diabetes (T2D). However, the role of myocardial insulin resistance (mIR) remains to be clarified. Methods: Two 18F-FDG PET/CT scans were performed on forty-three T2D patients at baseline and after hyperinsulinemic–euglycemic clamp (HEC). Myocardial insulin sensitivity (mIS) was determined by measuring the increment in myocardial 18F-FDG uptake after HEC. Coronary artery calcium scoring (CACs) and myocardial radiodensity (mRD) were assessed by CT. Results: After HEC, seventeen patients exhibited a strikingly enhancement of myocardial 18F-FDG uptake and twenty-six a marginal increase, thus revealing mIS and mIR, respectively. Patients with mIR showed higher mRD (HU: 38.95 [33.81–44.06] vs. 30.82 [21.48–38.02]; p = 0.03) and CACs > 400 (AU: 52% vs. 29%; p = 0.002) than patients with mIS. In addition, HOMA-IR and mIS only showed a correlation in those patients with mIR. Conclusions: 18F-FDG PET combined with HEC is a reliable method for identifying patients with mIR. This subgroup of patients was found to be specifically at high risk of developing cardiovascular events and showed myocardial structural changes. Moreover, the gold-standard HOMA-IR index was only associated with mIR in this subgroup of patients. Our results open up a new avenue for stratifying patients with cardiovascular risk in T2D.

1 November 2016 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
SASantiago Aguadé-Bruix
Santiago Aguadé-Bruix
GRGuillermo Romero-Farina
Guillermo Romero-Farina
JCJaume Candell-Riera
Jaume Candell-Riera
MPMaría Nazarena Pizzi
María Nazarena Pizzi
DGDavid García-Dorado
David García-Dorado